Variability in the therapeutic management of advanced ovarian cancer patients: a five-country survey of oncologists
Céline Audibert,1 Anna Perlaky,2 Mark Stuntz,2 Daniel Glass2 1Deerfield Institute, Epalinges, Switzerland; 2Deerfield Institute, New York, NY, USA Background: Advanced ovarian cancer patients have a poor prognosis, mainly because the disease is diagnosed at a late stage. A number of the...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/variability-in-the-therapeutic-management-of-advanced-ovarian-cancer-p-peer-reviewed-article-DDDT |